Cogent Biosciences Inc (COGT)
7.53
+0.24
(+3.29%)
USD |
NASDAQ |
May 03, 16:00
7.52
-0.01
(-0.13%)
After-Hours: 20:00
Cogent Biosciences Cash from Investing (Quarterly): 10.49M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.49M |
| September 30, 2023 | -90.54M |
| June 30, 2023 | -77.66M |
| March 31, 2023 | 59.88M |
| December 31, 2022 | 28.41M |
| September 30, 2022 | -151.54M |
| June 30, 2022 | -1.144M |
| March 31, 2022 | -0.441M |
| December 31, 2021 | -0.433M |
| September 30, 2021 | -1.163M |
| June 30, 2021 | -0.123M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 8.42M |
| Date | Value |
|---|---|
| June 30, 2020 | 0.00 |
| March 31, 2020 | |
| December 31, 2019 | -0.013M |
| September 30, 2019 | 0.226M |
| June 30, 2019 | 7.996M |
| March 31, 2019 | 14.95M |
| December 31, 2018 | 15.00M |
| September 30, 2018 | 9.914M |
| June 30, 2018 | -41.37M |
| March 31, 2018 | 5.925M |
| December 31, 2017 | 4.90M |
| September 30, 2017 | 5.725M |
| June 30, 2017 | 3.783M |
| March 31, 2017 | -0.82M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-151.54M
Minimum
Sep 2022
59.88M
Maximum
Mar 2023
-11.54M
Average
-0.0065M
Median
Cash from Investing (Quarterly) Benchmarks
| QuidelOrtho Corp | -55.10M |
| NeuroOne Medical Technologies Corp | -0.0371M |
| Agios Pharmaceuticals Inc | 95.51M |
| Tenon Medical Inc | -0.092M |
| DIH Holding US Inc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -44.07M |
| Free Cash Flow | -156.42M |
| Free Cash Flow Per Share (Quarterly) | -0.5113 |
| Free Cash Flow Yield | -26.09% |